Asunto(s)
Síndromes de Inmunodeficiencia/complicaciones , Síndromes de Inmunodeficiencia/inmunología , Vacunación/métodos , Anticuerpos Antibacterianos/sangre , Anticuerpos Antivirales/sangre , Formación de Anticuerpos/inmunología , Contraindicaciones , Alemania , Humanos , Monitorización Inmunológica , Programas Nacionales de Salud , Factores de Riesgo , Vacunación/efectos adversos , Cobertura de Vacunación , Vacunas/efectos adversosRESUMEN
Folk medicine has long employed leaves from Eriobotrya japonica Lindl. (Rosaceae) (LEJ) as relieving many diseases including chronic bronchitis and high fever. In this study, we investigated the immunomodulatory effects of leaves from LEJ water extracts (LEJE) in LP-BM5 murine leukemia viruses (MuLV)-induced immune-deficient animal model. Dietary supplementation of LEJE (100, 300, 500 mg/kg) began on the day of LP-BM5 MuLV infection and continued for 12 weeks. Dietary supplementation of LEJE inhibited LP-BM5 MuLV-induced splenomegaly and lymphadenopathy. Moreover, LEJE attenuated reductions of T- and B-cell proliferation and Th1/Th2 cytokine imbalance in LP-BM5. We found that dietary supplements of LEJE suppressed the hypergammaglobulinemia by ameliorating LP-BM5 MuLV infection-induced B-cell dysfunction and production of pro-inflammatory cytokines. We suggest that Eriobotrya japonica may have beneficial immunomodulatory effects, improving the balance of Th1/Th2 cytokines and anti-inflammatory effects.
Asunto(s)
Antivirales/farmacología , Eriobotrya/química , Síndromes de Inmunodeficiencia/inmunología , Síndromes de Inmunodeficiencia/virología , Virus de la Leucemia Murina , Extractos Vegetales/farmacología , Animales , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/inmunología , Antivirales/administración & dosificación , Antivirales/química , Ácido Clorogénico/química , Citocinas/metabolismo , Modelos Animales de Enfermedad , Femenino , Síndromes de Inmunodeficiencia/tratamiento farmacológico , Síndromes de Inmunodeficiencia/metabolismo , Mediadores de Inflamación/metabolismo , Activación de Linfocitos/efectos de los fármacos , Activación de Linfocitos/inmunología , Linfocitos/efectos de los fármacos , Linfocitos/inmunología , Linfocitos/metabolismo , Ratones , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Bazo/citología , Bazo/inmunología , Bazo/metabolismo , Subgrupos de Linfocitos T/efectos de los fármacos , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/metabolismoRESUMEN
Anemia in elderly population have a great incidence and is related to increased mortality risk. The incidence of nutrition in anemia is about one third of the total. Caloric and protein restriction, iron, vitamin B12, folic deficiency are the causes of nutritional anemia. Protein and energy malnutrition stimulate an increased cytokines production with induction of inflammation, immunodeficiency and anemia. Anorexia and obesity can be associated with anemia due to increased cytokines and hepdicin serum level. Macrophages activity is inhibited and a decrease in red blood cells (RBC), hemoglobin (Hb) concentration due to ineffective erythropoiesis is observed. An adequate energy and protein diet is necessary to reduce inflammation and increase iron absorption. A minimum of 1700 kcal/day and 1.7 gr/kg/day of protein intake are necessary to maintain anabolism in chronic patients to prevent and treat anemia. Iron supplementation by intravenous injection is safe and effective to correct severe iron deficiency. The supplementation of vitamins and oligomineral are useful to reduce oxidative stress and improve RBC longevity. Anemia in elderly could be prevented by an adequate nutrition, a simple and not expensive intervention, and associated to physical exercise reduce the incidence of mortality rate.
Asunto(s)
Anemia/prevención & control , Dieta Saludable , Suplementos Dietéticos , Fenómenos Fisiológicos Nutricionales del Anciano , Envejecimiento Saludable , Estilo de Vida Saludable , Cooperación del Paciente , Anciano , Anciano de 80 o más Años , Anemia/epidemiología , Anemia/etiología , Anemia/inmunología , Anemia Ferropénica/epidemiología , Anemia Ferropénica/etiología , Anemia Ferropénica/inmunología , Anemia Ferropénica/prevención & control , Animales , Anorexia/epidemiología , Anorexia/mortalidad , Anorexia/fisiopatología , Anorexia/terapia , Terapia Combinada , Hogares para Ancianos , Humanos , Síndromes de Inmunodeficiencia/epidemiología , Síndromes de Inmunodeficiencia/etiología , Síndromes de Inmunodeficiencia/inmunología , Síndromes de Inmunodeficiencia/prevención & control , Desnutrición/epidemiología , Desnutrición/mortalidad , Desnutrición/fisiopatología , Desnutrición/terapia , Casas de Salud , Apoyo Nutricional , Obesidad/epidemiología , Obesidad/mortalidad , Obesidad/fisiopatología , Obesidad/terapiaRESUMEN
It is established that arabinogalactan and pectinaceous polysaccharides isolated from Ferula kuchistanica are capable of stimulating a primary immune response in mice by increasing the number of antibody-producing cells in the spleen in response to immunization with sheep red blood cells in both intact animals (on average by 51.0%; p < 0.005) and those with secondary immunodeficiency caused by irradiation (on average by 164.4%; p < 0.005). The treatment with compounds studied also significantly increased the functional condition of cells of the mononuclear phagocyte system (on average by 27.0%; p < 0.005).
Asunto(s)
Adyuvantes Inmunológicos , Ferula/química , Galactanos , Síndromes de Inmunodeficiencia , Pectinas , Fagocitos/inmunología , Adyuvantes Inmunológicos/química , Adyuvantes Inmunológicos/aislamiento & purificación , Adyuvantes Inmunológicos/farmacología , Animales , Modelos Animales de Enfermedad , Femenino , Galactanos/química , Galactanos/aislamiento & purificación , Galactanos/farmacología , Síndromes de Inmunodeficiencia/tratamiento farmacológico , Síndromes de Inmunodeficiencia/inmunología , Masculino , Ratones , Pectinas/química , Pectinas/aislamiento & purificación , Pectinas/farmacologíaRESUMEN
AIM: This study was carried out to determine the effects of formaldehyde (FA) inhalation on the humoral immunity of rats and the protective effect of Nigella sativa (NS) oil. MATERIALS AND METHODS: The rats (n = 33) were divided into five groups, with five animals in the control group (FA-free air) and seven in the other four groups. Group FA1 was exposed to FA (5 ppm), group FA + NS1 was treated with NS and exposed to FA (5 ppm), group FA2 was exposed to FA (10 ppm), and group FA + NS2 was treated with NS and exposed to FA (10 ppm). At the end of a 4-week study period, blood samples were collected. Enzyme-linked immunosorbent assay was used to determine the levels of serum total immunoglobulin A (IgA), total immunoglobulin M (IgM), total immunoglobulin G (IgG), and complement 3 (C3). RESULTS: FA inhalation significantly increased serum IgA, IgM, and C3 levels and decreased serum IgG levels compared with the control group. NS administration decreased serum IgA, IgM, and C3 levels, which were induced by FA inhalation. CONCLUSION: FA inhalation significantly increased acute antibody responses and C3 levels in a dose-dependent manner compared with the control group. FA inhalation decreased the secondary immune response compared with the control group. Levels of acute antibody responses and complement following exposure to FA inhalation returned to normal following treatment with NS (immunoregulatory effect). However, NS did not affect the secondary immune response.
Asunto(s)
Carcinógenos Ambientales/toxicidad , Suplementos Dietéticos , Formaldehído/toxicidad , Inmunidad Humoral/efectos de los fármacos , Síndromes de Inmunodeficiencia/prevención & control , Aceites de Plantas/uso terapéutico , Sustancias Protectoras/uso terapéutico , Administración por Inhalación , Contaminantes Atmosféricos/química , Contaminantes Atmosféricos/toxicidad , Animales , Formación de Anticuerpos/efectos de los fármacos , Anticarcinógenos/uso terapéutico , Cámaras de Exposición Atmosférica , Carcinógenos Ambientales/administración & dosificación , Carcinógenos Ambientales/química , Complemento C3/agonistas , Complemento C3/análisis , Complemento C3/antagonistas & inhibidores , Relación Dosis-Respuesta a Droga , Formaldehído/administración & dosificación , Formaldehído/antagonistas & inhibidores , Inmunoglobulina A/análisis , Inmunoglobulina A/biosíntesis , Inmunoglobulina A/química , Inmunoglobulina M/análisis , Inmunoglobulina M/biosíntesis , Inmunoglobulina M/química , Síndromes de Inmunodeficiencia/sangre , Síndromes de Inmunodeficiencia/inducido químicamente , Síndromes de Inmunodeficiencia/inmunología , Exposición por Inhalación/efectos adversos , Masculino , Ratas Sprague-DawleyRESUMEN
A preclinical study of the immunocorrection action of the sum of active substances isolated from ethereal-oil plants Coluria geoides (Pall.) Ledeb. (Rosaceae family) with respect to experimental immunodeficiency showed that preparations relieve symptoms of immunodeficiency caused by the administration of cyclophosphan: suppressed synthesis of anti-erythrocyte antibodies (agglutinine) and proliferative processes in the spleen. Under the influence of C. geoides preparations, the absolute numbers of cariocytes and antibody forming cells in spleen significantly increased (compared to the group of animals with experimental immunodeficiency) and in some cases reached the background level. The drugs studied produced a more pronounced stimulating effect on the synthesis of specific immunoglobulins and proliferation of antibody forming cells of spleen as compared to the effect of Echinacea tincture. Preparation C-2 (extract from underground organs and grass of C. geoides obtained by percolation method with 70% ethanol) is most promising for in-depth research and the development of new effective drugs with immunocorrecting properties.
Asunto(s)
Proliferación Celular/efectos de los fármacos , Síndromes de Inmunodeficiencia/tratamiento farmacológico , Factores Inmunológicos , Extractos Vegetales , Rosaceae/química , Bazo/inmunología , Animales , Evaluación Preclínica de Medicamentos , Femenino , Síndromes de Inmunodeficiencia/inmunología , Síndromes de Inmunodeficiencia/patología , Factores Inmunológicos/química , Factores Inmunológicos/farmacología , Ratones , Ratones Endogámicos CBA , Extractos Vegetales/química , Extractos Vegetales/farmacología , Bazo/patologíaRESUMEN
We studied the immunomodulatory and clinical effects of the empirical formula "tiaomian III decoction" on maternal blood blocking antibody deficiency and recurrent spontaneous abortion. Sixty-one patients with blocking antibody deficiency were divided in the experimental group (N = 31), who took tiaomian III decoction, and the control group (N = 30), who received active immunotherapy with paternal lymphocytes; both treatments lasted 3 months. Blocking antibodies, anti-idiotypic antibodies, interleukin, T-lymphocyte subsets, and macrophage colony-stimulating factor (M-CSF) were tested. After treatment, the positive conversion rate reached 87.1 and 86.7% in the experimental and control groups, respectively. After treatment, CD4 levels decreased while CD8 levels increased in both groups. The CD4/CD8 ratio was higher than normal and increased significantly from pre-treatment (P < 0.05). IL-10 and M-CSF levels increased significantly in both groups (P < 0.05). The 1-year conception rates of the experimental and control groups were 58.1 and 46.7%, respectively (P < 0.05). The results show the tiaomian III decoction can increase the positive conversion rate of maternal blocking antibodies and promote the production of IL-10 and M-CSF. Thus, it strengthens the maternal body's protection of the fetus and maintenance of conception. The higher conception rate of the experimental group demonstrates the positive clinic efficacy of the tiaomian III decoction on maternal blood blocking antibody deficiency and recurrent spontaneous abortion.
Asunto(s)
Aborto Habitual/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Fármacos para la Fertilidad/uso terapéutico , Síndromes de Inmunodeficiencia/tratamiento farmacológico , Factores Inmunológicos/uso terapéutico , Aborto Habitual/inmunología , Adulto , Anticuerpos Bloqueadores/sangre , Femenino , Humanos , Síndromes de Inmunodeficiencia/inmunología , Embarazo , Subgrupos de Linfocitos T/efectos de los fármacos , Subgrupos de Linfocitos T/inmunología , Resultado del TratamientoRESUMEN
The intra-uterine environment provides the first regulatory connection for the developing fetus and shapes its physiological responses in preparation for postnatal life. Psychological stress acts as a programming determinant by setting functional parameters to abnormal levels, thus inducing postnatal maladaptation. The effects of prenatal maternal stress (PNMS) on the developing immune system have been documented mostly through animal studies, but inconsistent results and methodological differences have hampered the complete understanding of these findings. As the immune system follows a similar ontogenic pattern in all mammals, a translational framework based on the developmental windows of vulnerability proposed by immunotoxicology studies was created to integrate these findings. The objective of this review is to examine the available literature on PNMS and immune function in the offspring through the above framework and gain a better understanding of these results by elucidating the moderating influence of the stressor type, timing and duration, and the offspring species, sex and age at assessment. The evaluation of the literature through this framework showed that the effects of PNMS are parameter specific: the moderating effects of timing in gestation were relevant for lymphocyte population numbers, Natural Killer cell function and mitogen-induced proliferation. The presence of an important and directional sexual dimorphism was evident and the influence of the type or duration of PNMS paralleled that of stress in non-pregnant animals. In conclusion, PNMS is a relevant factor in the programming of immune function. Its consequences may be related to disorders with an important immune component such as allergies.
Asunto(s)
Sistema Inmunológico/embriología , Complicaciones del Embarazo/fisiopatología , Efectos Tardíos de la Exposición Prenatal/inmunología , Estrés Psicológico/fisiopatología , Inmunidad Adaptativa , Animales , Citocinas/inmunología , Modelos Animales de Enfermedad , Sistema Endocrino/embriología , Sistema Endocrino/inmunología , Femenino , Edad Gestacional , Hematopoyesis Extramedular , Humanos , Hipersensibilidad/embriología , Hipersensibilidad/inmunología , Inmunidad Innata , Inmunocompetencia , Síndromes de Inmunodeficiencia/embriología , Síndromes de Inmunodeficiencia/inmunología , Intestinos/microbiología , Subgrupos Linfocitarios/inmunología , Masculino , Microbiota , Embarazo , Psiconeuroinmunología , Caracteres Sexuales , Especificidad de la EspecieAsunto(s)
Terapias Complementarias/métodos , Síndromes de Inmunodeficiencia/diagnóstico , Síndromes de Inmunodeficiencia/terapia , Trastornos de Estrés Traumático Agudo/diagnóstico , Trastornos de Estrés Traumático Agudo/terapia , Terapias Complementarias/educación , Costos y Análisis de Costo/economía , Financiación Personal/economía , Alemania , Humanos , Síndromes de Inmunodeficiencia/economía , Síndromes de Inmunodeficiencia/inmunología , Revisión de Utilización de Seguros/economía , Trastornos de Estrés Traumático Agudo/economía , Trastornos de Estrés Traumático Agudo/inmunología , Procedimientos Innecesarios/economíaRESUMEN
PURPOSE: Microparticles containing solid lipid nanoparticles (SLNs) are receiving increased attention as carriers for the lung delivery of the SLNs. Thus, we aim to prepare the hybrid microparticles and thoroughly evaluate their feasibility for the pulmonary drug delivery. METHODS: The microparticles were prepared by co-spray-drying the thymopentin (TP5)-loaded SLNs with bulking agents. Thereafter, we systematically estimated the potential of the microparticles as the carriers for the pulmonary delivery of the SLNs, including the investigations of their characteristics, aerodynamic properties, pharmacokinetics and pharmacodynamics. RESULTS: The spherical and hollow microparticles presented a size of 4.1 +/- 0.1 microm and a low tap density of 0.175 +/- 0.02 g/cm(3). In addition, the microparticles showed a high aerosolization efficiency (emitted dose of 98.0% +/- 1.23% and respirable fraction of 51.07% +/- 1.21%). Furthermore, the SLNs could be easily recovered from the microparticles without essential changes on their characteristics and the drug release behavior. The pharmacokinetic and pharmacodynamic studies suggested that, compared to i.v. TP5 solution, the bioavailability and therapeutic efficacy of TP5 were remarkably strengthened after the pulmonary administration of the microparticles. CONCLUSIONS: Taken together, we believe the microparticles were suitable for inhalation and possessed an ample potential for the pulmonary delivery of the SLNs.
Asunto(s)
Adyuvantes Inmunológicos/farmacocinética , Portadores de Fármacos/química , Lípidos/química , Pulmón/metabolismo , Nanopartículas/química , Timopentina/farmacocinética , Adyuvantes Inmunológicos/administración & dosificación , Adyuvantes Inmunológicos/química , Adyuvantes Inmunológicos/uso terapéutico , Administración por Inhalación , Animales , Relación CD4-CD8 , Estabilidad de Medicamentos , Síndromes de Inmunodeficiencia/sangre , Síndromes de Inmunodeficiencia/tratamiento farmacológico , Síndromes de Inmunodeficiencia/inmunología , Subgrupos Linfocitarios/citología , Subgrupos Linfocitarios/efectos de los fármacos , Subgrupos Linfocitarios/inmunología , Microscopía Confocal , Ratas , Ratas Wistar , Superóxido Dismutasa/metabolismo , Propiedades de Superficie , Timopentina/administración & dosificación , Timopentina/química , Timopentina/uso terapéuticoRESUMEN
The influence of Sorbus sibirica, Calendula officinalis and Althaea officinalis extracts on the humoral immune response and nonspecific resistance of mice to immunosuppression by cyclophosphan was studied. It was shown that these extracts are not inferior to Echinacea purpurea tincture in terms of stimulation of humoral immune response, phagocytic and bactericidal activity of peritoneal macrophages but exceed effect of E. purpurea on phagocytic activity of peripheral blood neutrophils.
Asunto(s)
Inmunidad Innata , Síndromes de Inmunodeficiencia/tratamiento farmacológico , Terapia de Inmunosupresión/métodos , Inmunosupresores/uso terapéutico , Macrófagos Peritoneales/inmunología , Fitoterapia/métodos , Preparaciones de Plantas/uso terapéutico , Animales , Ciclofosfamida/uso terapéutico , Modelos Animales de Enfermedad , Echinacea , Síndromes de Inmunodeficiencia/inmunología , Síndromes de Inmunodeficiencia/patología , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/patología , Masculino , Ratones , Ratones Endogámicos CBA , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , Neutrófilos/patología , Resultado del TratamientoRESUMEN
The observation that only a fraction of individuals infected by infectious agents develop clinical disease raises fundamental questions about the actual pathogenesis of infectious diseases. Epidemiological and experimental evidence is accumulating to suggest that human genetics plays a major role in this process. As we discuss here, human predisposition to infectious diseases seems to cover a continuous spectrum from monogenic to polygenic inheritance. Although many studies have provided proof of principle that infectious diseases may result from various types of inborn errors of immunity, the genetic determinism of most infectious diseases in most patients remains unclear. However, in the future, studies in human genetics are likely to establish a new paradigm for infectious diseases.
Asunto(s)
Enfermedades Transmisibles/genética , Enfermedades Transmisibles/historia , Enfermedades Transmisibles/inmunología , Femenino , Predisposición Genética a la Enfermedad , Genética Médica/historia , Genoma Humano , Historia del Siglo XIX , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Síndromes de Inmunodeficiencia/genética , Síndromes de Inmunodeficiencia/inmunología , Masculino , Modelos Genéticos , LinajeRESUMEN
Immunodeficiencies are characterized as primary (genetic) or secondary (acquired). Primary immunodeficiencies are relatively uncommon; however, clinically, they present a significant challenge to the practitioner, especially if the underlying disorder goes unrecognized. Secondary immunodeficiencies may present at any age, but failure of passive transfer in neonatal foals is most commonly encountered. This article provides a general overview of clinical signs and diagnosis of primary and secondary immunodeficiencies currently recognized in horses.
Asunto(s)
Agammaglobulinemia/veterinaria , Enfermedades de los Caballos/inmunología , Inmunidad Materno-Adquirida , Síndromes de Inmunodeficiencia/veterinaria , Animales , Animales Lactantes/inmunología , Calostro/inmunología , Enfermedades de los Caballos/diagnóstico , Enfermedades de los Caballos/patología , Caballos , Inmunización Pasiva/veterinaria , Inmunoglobulina M/deficiencia , Síndromes de Inmunodeficiencia/diagnóstico , Síndromes de Inmunodeficiencia/inmunología , Síndromes de Inmunodeficiencia/patología , Inmunodeficiencia Combinada Grave/diagnóstico , Inmunodeficiencia Combinada Grave/inmunología , Inmunodeficiencia Combinada Grave/patología , Inmunodeficiencia Combinada Grave/veterinariaRESUMEN
The present study examines serum zinc concentrations in patients with chronic fatigue syndrome (CFS) versus normal volunteers. Serum zinc levels were determined by means of an atomic absorption method. We found that serum zinc was significantly lower in the CFS patients than in the normal controls. There was a trend toward a significant negative correlation between serum zinc and the severity of CFS and there was a significant and negative correlation between serum zinc and the subjective experience of infection. We found that serum zinc was significantly and negatively correlated to the increase in the alpha2 protein fraction and positively correlated to decreases in the expression of mitogen-induced CD69+ (a T cell activation marker) on CD3+ as well as CD3+CD8+ T cells. These results show that CFS is accompanied by a low serum zinc status and that the latter is related to signs of inflammation and defects in early T cell activation pathways. Since zinc is a strong anti-oxidant, the present results further support the findings that CFS is accompanied by increased oxidative stress. The results of these reports suggest that some patients with CFS should be treated with specific antioxidants, including zinc supplements.
Asunto(s)
Síndrome de Fatiga Crónica/inmunología , Síndromes de Inmunodeficiencia/inmunología , Estrés Oxidativo/fisiología , Zinc/deficiencia , Adulto , Linfocitos T CD8-positivos/inmunología , Evaluación de la Discapacidad , Síndrome de Fatiga Crónica/diagnóstico , Síndrome de Fatiga Crónica/psicología , Femenino , Humanos , Síndromes de Inmunodeficiencia/diagnóstico , Síndromes de Inmunodeficiencia/psicología , Inflamación/inmunología , Integrina beta1/sangre , Activación de Linfocitos/inmunología , Recuento de Linfocitos , Masculino , Persona de Mediana Edad , Valores de Referencia , Linfocitos T Reguladores/inmunología , Zinc/sangre , alfa-Macroglobulinas/metabolismoRESUMEN
Fifty-eight patients aged from 18 to 65 years with peritonitis of different etiology in toxic and terminal phases were treated. Nasoenteral intubation, enterosorption and early nutritious support with pectin-containing preparation (PCP) were carried out in all the patients just after surgery with standard course of 5 days. Baseline data was compared with that after PCP-supported treatment. Powder products of red beet were used as PCP. Immunodeficiency in peritonitis is characterized by imbalance of stress-realizing and stress-limiting mechanisms of immunocompetent cells. Enterosorption and early nutritious support with PCP in peritonitis decrease the level of plasmic cortisol and enhance stress-limiting reception that reduces a harmful effect of cortisol and reestablishes immunity.
Asunto(s)
Antidiarreicos/uso terapéutico , Enteroadsorción , Síndromes de Inmunodeficiencia/terapia , Apoyo Nutricional , Pectinas/uso terapéutico , Peritonitis/complicaciones , Estrés Fisiológico/inmunología , Adolescente , Adulto , Anciano , Linfocitos B/inmunología , Relación CD4-CD8 , Estudios de Seguimiento , Humanos , Inmunidad Celular/inmunología , Síndromes de Inmunodeficiencia/etiología , Síndromes de Inmunodeficiencia/inmunología , Intubación Gastrointestinal , Persona de Mediana Edad , Peritonitis/inmunología , Estrés Fisiológico/complicaciones , Linfocitos T/inmunología , Resultado del TratamientoAsunto(s)
Síndromes de Inmunodeficiencia/diagnóstico , Pruebas Inmunológicas , Psiconeuroinmunología , Trastornos Somatomorfos/diagnóstico , Animales , Costos y Análisis de Costo , Diagnóstico Diferencial , Medicina Familiar y Comunitaria/economía , Femenino , Alemania , Humanos , Inmunocompetencia/inmunología , Síndromes de Inmunodeficiencia/economía , Síndromes de Inmunodeficiencia/inmunología , Pruebas Inmunológicas/economía , Ratones , Persona de Mediana Edad , Naturopatía/economía , Trastornos Somatomorfos/economía , Trastornos Somatomorfos/inmunología , Procedimientos Innecesarios/economíaRESUMEN
Hindlimb unloading is a ground-based model that simulates some of the aspects of spaceflight conditions, including lack of load bearing on hindlimbs and a fluid shift to the head. It has been shown that treatment with active hexose correlated compound (AHCC) restores resistance to infection in mice maintained under hindlimb-unloading conditions. The present study was designed to clarify the mechanisms by which AHCC enhances resistance to infection in this model. We hypothesized that oral administration of AHCC will enhance the function of the immune system, which could lead to the increased resistance to infection observed in this model. AHCC or the excipient was orally administered to mice, and the function of the immune system was assessed in spleen and peritoneal cells isolated from those groups. The results of the present study showed that administration of AHCC for 1 wk before and throughout the second day of the hindlimb-unloading period enhanced the function of the immune system assessed by spleen cell proliferation and cytokine production in spleens and nitric oxide and cytokine production in peritoneal cells. These findings suggest that AHCC can be used as a potent immunoenhancer, especially in cases in which the immune system is suppressed by any condition, including diseases such as human immunodeficiency virus infection and cancer.
Asunto(s)
Citocinas/inmunología , Suplementos Dietéticos , Suspensión Trasera/efectos adversos , Inmunidad Innata/efectos de los fármacos , Inmunidad Innata/inmunología , Síndromes de Inmunodeficiencia/inmunología , Síndromes de Inmunodeficiencia/prevención & control , Polisacáridos/administración & dosificación , Administración Oral , Animales , Citocinas/sangre , Susceptibilidad a Enfermedades/inmunología , Susceptibilidad a Enfermedades/terapia , Femenino , Suspensión Trasera/métodos , Síndromes de Inmunodeficiencia/etiología , Ratones , Vuelo Espacial/métodos , Resultado del Tratamiento , Simulación de Ingravidez/efectos adversos , Simulación de Ingravidez/métodosRESUMEN
BACKGROUND AND OBJECTIVES: Individuals with primary or secondary immune-deficiency diseases may be at risk for vaccinia infection if widespread smallpox-immunization programmes are implemented in the United States of America (USA) for bioterrorism preparedness. The objective of this study was to determine whether commercial immune globulin (intravenous, human) products contain biologically active antibodies to vaccinia that have the potential to protect people, with immune deficiencies, from complications of vaccinia. MATERIALS AND METHODS: Eight currently United States (US)-licensed and two European intravenous immunoglobulin (IVIG) products were tested in a vaccinia plaque-reduction neutralization assay. The in vivo activity of five of these lots was assessed in severely immune-deficient mice. RESULTS: All tested products contained neutralizing anti-vaccinia activity, in vitro and in vivo. CONCLUSIONS: The use of IVIG by individuals with inherited or acquired humoral immune deficiencies may provide some protection if they are inadvertently exposed to vaccinia.